CR20110590A - STABLE FORMS OF N- (2,6-DIMETIL-4-MORFOLIN-4-IL-FENIL) 3,3- DIMETIL-BUTIRAMIDA - Google Patents

STABLE FORMS OF N- (2,6-DIMETIL-4-MORFOLIN-4-IL-FENIL) 3,3- DIMETIL-BUTIRAMIDA

Info

Publication number
CR20110590A
CR20110590A CR20110590A CR20110590A CR20110590A CR 20110590 A CR20110590 A CR 20110590A CR 20110590 A CR20110590 A CR 20110590A CR 20110590 A CR20110590 A CR 20110590A CR 20110590 A CR20110590 A CR 20110590A
Authority
CR
Costa Rica
Prior art keywords
dimetil
butiramida
morfolin
fenil
stable forms
Prior art date
Application number
CR20110590A
Other languages
Spanish (es)
Inventor
Svend Treppendahl
Karin Liltorp
De Diego Heidi Lopez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20110590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of CR20110590A publication Critical patent/CR20110590A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cosmetics (AREA)

Abstract

Se proporcinan formas polimórficas de N-(2,6-dimetil-4-morfolin-4-il-fenil)3,3- dimetil-butiramida, junto con un proceso para la elaboración de dicho compuesto.Polymorphic forms of N- (2,6-dimethyl-4-morpholin-4-yl-phenyl) 3,3-dimethyl-butyramide are provided, together with a process for the preparation of said compound.

CR20110590A 2009-05-11 2011-11-11 STABLE FORMS OF N- (2,6-DIMETIL-4-MORFOLIN-4-IL-FENIL) 3,3- DIMETIL-BUTIRAMIDA CR20110590A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200900597 2009-05-11

Publications (1)

Publication Number Publication Date
CR20110590A true CR20110590A (en) 2012-02-22

Family

ID=42237259

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110590A CR20110590A (en) 2009-05-11 2011-11-11 STABLE FORMS OF N- (2,6-DIMETIL-4-MORFOLIN-4-IL-FENIL) 3,3- DIMETIL-BUTIRAMIDA

Country Status (23)

Country Link
EP (1) EP2430008A2 (en)
JP (1) JP2012526152A (en)
KR (1) KR20120022934A (en)
CN (1) CN102459208A (en)
AR (1) AR076556A1 (en)
AU (1) AU2010246724B2 (en)
BR (1) BRPI1013930A2 (en)
CA (1) CA2761383A1 (en)
CL (1) CL2011002814A1 (en)
CO (1) CO6460741A2 (en)
CR (1) CR20110590A (en)
DO (1) DOP2011000351A (en)
EA (1) EA201171381A1 (en)
GE (1) GEP20146006B (en)
IL (1) IL216148A0 (en)
MA (1) MA33351B1 (en)
MX (1) MX2011011885A (en)
NZ (1) NZ596738A (en)
SG (1) SG175968A1 (en)
TN (1) TN2011000557A1 (en)
TW (1) TW201041857A (en)
WO (1) WO2010130260A2 (en)
ZA (1) ZA201108112B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
JP5419691B2 (en) * 2006-08-23 2014-02-19 バレアント ファーマシューティカルズ インターナショナル Derivatives of 4- (N-azacycloalkyl) anilide as potassium channel modulators
JP2011513196A (en) * 2007-08-01 2011-04-28 ハー・ルンドベック・アクチエゼルスカベット Use of a KCNQ potassium channel opener to alleviate symptoms of or treat a disorder or condition in which the dopaminergic system is disrupted

Also Published As

Publication number Publication date
ZA201108112B (en) 2013-01-30
TW201041857A (en) 2010-12-01
BRPI1013930A2 (en) 2019-09-24
MX2011011885A (en) 2011-12-06
CL2011002814A1 (en) 2012-04-13
TN2011000557A1 (en) 2013-05-24
DOP2011000351A (en) 2012-01-31
MA33351B1 (en) 2012-06-01
JP2012526152A (en) 2012-10-25
SG175968A1 (en) 2011-12-29
WO2010130260A3 (en) 2011-06-16
EP2430008A2 (en) 2012-03-21
WO2010130260A9 (en) 2012-10-18
CA2761383A1 (en) 2010-11-18
IL216148A0 (en) 2012-01-31
EA201171381A1 (en) 2012-05-30
WO2010130260A2 (en) 2010-11-18
CO6460741A2 (en) 2012-06-15
AR076556A1 (en) 2011-06-22
AU2010246724A1 (en) 2011-12-08
AU2010246724B2 (en) 2013-03-21
CN102459208A (en) 2012-05-16
NZ596738A (en) 2013-04-26
GEP20146006B (en) 2014-01-10
KR20120022934A (en) 2012-03-12

Similar Documents

Publication Publication Date Title
BRPI0923325A2 (en) methods for using a compound, and for suppressing the production of a free isocyanate compound.
UY34765A (en) NEW COMPOUNDS.
UY34559A (en) BROMODOMINIUM INHIBITORS
UY34515A (en) SUBSTITUTED TRIAZOLOPIRIDINS
UA113643C2 (en) N-CYCLYLAMIDES AS NEMATOCIDES
CR10157A (en) CHEMICAL COMPOUNDS
CR20140448A (en) METHOD FOR JOINING METAL PARTS
UY34302A (en) HEXAHYDROPYRAN [3,4-d] [1,3] THIAZIN-2-AMINE COMPOUNDS
DK3320912T3 (en) Indoleamine-2,3-dioxygenase-based immunotherapy
AR061311A1 (en) PROCESSES TO PREPARE CINACALCET CHLORHYDRATE AND POLYMORPHIC FORMS OF THE SAME
AR058253A1 (en) PROCEDURE FOR THE PREPARATION OF FERRI-SUCCINILCASEINA
RS52255B (en) Nalmefene hydrochloride dihydrate
CL2012002082A1 (en) Process for the preparation of lacosamide, by hydroxymethylation; intermediary compounds
EA201000258A1 (en) NEW HERBICIDES
BRPI1014691A2 (en) Compound, and process for the preparation of a compound.
UY34329A (en) TRIAZOLOPIRIDINE COMPOUNDS
ECSP13012914A (en) SYNTHESIS OF DERIVATIVES OF 2-CARBOXAMIDA-CICLOAMINO-UREA
UY34791A (en) N-ETHYL-4-HYDROXYL-1-METHYL-5- (METHYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) -2-OXO-N-PHENYL-1,2- DIHYDROQUINOLINE-3-CARBOXAMIDE
FR2973475B1 (en) LIGHTING MODULE, HOMOGENEITY OF IMPROVED LIGHTING.
ECSP11011190A (en) ANTI-RHD MONOCLONAL ANTIBODIES
UY34072A (en) INDOL SUBSTITUTED DERIVATIVES
CR20110208A (en) PROCESS FOR THE PREPARATION OF BENZONORBORNENOS
DK1931618T3 (en) Process for the preparation of anilines
CR20120169A (en) PROCESSES FOR THE PREPARATION OF 2- (1-PHENILETIL) -ISOINDOLIN-1-ONA
BRPI0922064A2 (en) process for preparing a secondary amide.